Trial intelligence / Profile preview

Calcium vs Placebo for Diastolic Dysfunction during CPB Separation

NCT00955266Phase 4Terminated

Sponsor
Brigham and Women's Hospital
Start
Jul 2009
Primary completion
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in hemodynamic instability comparing Calcium Chloride with Placebo (2 arms). Primary endpoint: Diastolic Dysfunction at 9 months. Started Jul 2009; status: terminated.

02

Drugs

calcium chloride
03

Conditions

hemodynamic instability

Beyond the preview

Go deeper on NCT00955266.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00955266.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call